Metraipolis › archive › dc_2fdacd4ff444

Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer — Europe PMC PMID:30180877

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/30180877
DOI
10.1186/s13058-018-1040-9
License (as archived)
solo-consultazione
Archived
2026-10-08T13:36:54.166Z
SHA-256 of the archived text
7595c6d2310b82ba24545e082e641f5041f2004a03f6a767534ee4c5a0fb2be0
Stable URL of this page
https://metraipolis.com/documento/dc_2fdacd4ff444

How to cite

Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer — Europe PMC PMID:30180877 — Europe PMC (en), https://europepmc.org/article/MED/30180877 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2fdacd4ff444 (Metraipolis archive dc_2fdacd4ff444, sha256 7595c6d2310b82ba24545e082e641f5041f2004a03f6a767534ee4c5a0fb2be0)
BibTeX
@misc{dc2fdacd4ff444,
  title = {Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer — Europe PMC PMID:30180877},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/30180877},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2fdacd4ff444; sha256 7595c6d2310b82ba24545e082e641f5041f2004a03f6a767534ee4c5a0fb2be0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/30180877. Agents can read the archived copy with the MCP tool read_document.